Home » Stocks » VINC

Vincera Pharma, Inc. (VINC)

Stock Price: $20.37 USD -0.56 (-2.68%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
Market Cap 282.48M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 8.20M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $20.37
Previous Close $20.93
Change ($) -0.56
Change (%) -2.68%
Day's Open 20.92
Day's Range 19.83 - 21.17
Day's Volume 35,100
52-Week Range 9.35 - 21.67


Hide News
GlobeNewsWire - 2 weeks ago

PALO ALTO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer throug...

GlobeNewsWire - 1 month ago

Business combination transaction with LifeSci Acquisition Corp. was completed on December 23, 2020

About VINC

Vincera Pharma, a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's product pipeline includes VIP152 that is in Phase 1 clinical trials for the treatment of solid tumors/nonHodgkin lymphoma and acute myeloid leukemia; VIP236, a small molecule drug conjugate for solid tumors; VIP943 for the treatment of leukemias and myelodysplastic syndromes; and VIP924 for B-cell malignancies. It also develops VIP217, an oral PTEFb/CDK9 inhibitor. The compan... [Read more...]

Dr. Ahmed M. Hamdy
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Vincera Pharma stock is "Strong Buy" and the 12-month stock price forecast is 33.00.

Price Target
Analyst Consensus: Strong Buy